NAI China Small Cap Index

Latest News

HQ Sustainable Maritime Schedules First Quarter 2009 Earnings Conference Call for May 11, 2009 at 4:30 p.m. ET- 2009-04-29

Harbin Electric to Report First Quarter 2009 Financial Results on May 8th- 2009-04-29

China Natural Gas Announces New Chief Financial Officer- 2009-04-28

SORL Auto Parts Announces Date of 2009 Annual Meeting of Stockholders- 2009-04-28

China BAK Reports Second Quarter Fiscal Year 2009 Financial Results- 2009-04-28

China Medical Technologies Receives SFDA Approval for Its Bladder Cancer FISH Probe- 2009-04-27

General Steel Announces Preliminary First Quarter 2009 Results- 2009-04-27

Far East Energy Announces 2009 Annual Meeting and Management Staff Addition- 2009-04-23

C O R R E C T I O N -- Sinovac Biotech Ltd./- 2009-04-23

Neo Material Technologies responds to Amended Pala Offer and waives proxy deposit deadline for meeting- 2009-04-22

China Medical Technologies Receives SFDA Approval for Its Bladder Cancer FISH Probe
2009-04-27 00:00

China Medical Technologies Receives SFDA Approval for Its Bladder Cancer FISH Probe

BEIJING, April 27, 2009 /PRNewswire-Asia-FirstCall via COMTEX News Network/ --
China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Bladder Cancer FISH Probe (the "Probe") from the State Food and Drug Administration (the "SFDA") in the People's Republic of China.

The Probe is an advanced molecular diagnostic test kit that uses DNA probes for early detection and monitoring the course of bladder cancer. It is designed to detect and identify whether aneuploidy for chromosomes 3, 7, 17 and loss of the p16 locus are present in the human bladder cells. A number of hospitals in China have applied the Probe for diagnosing patients with hematuria and have diagnosed patients with early-stage bladder cancer as well as early-stage ureteral cancer, which caused hematuria in these patients.

About China Medical Technologies, Inc.